Cancer Therapy : Preclinical Targeted Nanomedicine for Suppression of CD 44 and Simultaneous Cell Death Induction in Ovarian Cancer : An Optimal Delivery of siRNA and Anticancer Drug

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids.

  2013cited by this paper
• The possible "proton sponge " effect of polyethylenimine (PEI) does not include change in lysosomal pH.

  2013cited by this paper
• Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths

  2012cited by this paper
• Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases.

  2012cited by this paper
• Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA

  2011cited by this paper
• Multifunctional Triblock Nanocarrier (PAMAM-PEG-PLL) for the Efficient Intracellular siRNA Delivery and Gene Silencing

  2011cited by this paper
• Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.

  2011influential reference
• Poly(propyleneimine) dendrimers as potential siRNA delivery nanocarrier: from structure to function

  2011cited by this paper
• Non-viral systemic delivery of siRNA or antisense oligonucleotides targeted to Jun N-terminal kinase 1 prevents cellular hypoxic damage

  2010cited by this paper
• Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance

  2010cited by this paper
• Multifunctional Tumor-Targeted Polymer-Peptide-Drug Delivery System for Treatment of Primary and Metastatic Cancers

  2010cited by this paper
• Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.

  2009cited by this paper
• Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery.

  2009influential reference
• Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug

  2009cited by this paper
• Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells*

  2008cited by this paper
• Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery.

  2008cited by this paper
• Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer.

  2008cited by this paper
• Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?

  2008cited by this paper
• Targeted Sialic Acid–Doxorubicin Prodrugs for Intracellular Delivery and Cancer Treatment

  2007cited by this paper
• Targeted proapoptotic anticancer drug delivery system.

  2007cited by this paper
• Interfering with disease: a progress report on siRNA-based therapeutics

  2007cited by this paper
• JNK1 as a molecular target to limit cellular mortality under hypoxia.

  2006cited by this paper
• Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.

  2006cited by this paper
• The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.

  2005cited by this paper
• Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.

  2005cited by this paper
• Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

  2005cited by this paper
• Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells.

  2004cited by this paper
• Enhancement of the Efficacy of Chemotherapy for Lung Cancer by Simultaneous Suppression of Multidrug Resistance and Antiapoptotic Cellular Defense

  2004cited by this paper
• Therapeutic potential of RNA interference.

  2004cited by this paper
• Targeted Proapoptotic LHRH-BH3 Peptide

  2003cited by this paper
• The CD44 receptor is a molecular predictor of survival in ovarian cancer

  2003cited by this paper
• Disruption of the integrity of human peritoneal mesothelium by interleukin-1beta and tumor necrosis factor-alpha.

  2003cited by this paper
• The Lower-Generation Polypropylenimine Dendrimers Are Effective Gene-Transfer Agents

  2002cited by this paper
• Identification of CD44 Residues Important for Hyaluronan Binding and Delineation of the Binding Site*

  1998cited by this paper
• CD44 splice variant expression in clear cell carcinoma of the ovary.

  1998cited by this paper
• CD44: structure, function, and association with the malignant process.

  1997cited by this paper
• CD-44 is not involved in the metastatic spread of ovarian cancer in vivo.

  1995cited by this paper
• Expression and modulation of CD44 variant isoforms in humans

  1994cited by this paper
• Cancer of the ovary.

  1994cited by this paper
• Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.

  1992cited by this paper
• CD44 is the principal cell surface receptor for hyaluronate.

  1990cited by this paper

• siRNA and Ovarian Cancer

  2021cites this paper
• MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer

  2015cites this paper
• The Role of CD44 in Disease Pathophysiology and Targeted Treatment

  2015cites this paper
• Lentivirus-Based System for Fast Expression and Purification of Recombinant Proteins and its Implementation for Production of Human CD44 Extracellular Part

  2015cites this paper
• olymeric nanoparticle-mediated silencing of CD 44 receptor in CD 34 + cute myeloid leukemia cells

  2014cites this paper